ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Saol Therapeutics Announces FDA Approval of LYVISPAH™ (baclofen) Oral Granules and the Divesture of its Plasma-derived Hyperimmune Portfolio
December 09, 2021Saol Therapeutics announced that the FDA has approved Saol's LYVISPAH™ (baclofen) oral granules. -
Survey shows efficacy of BoNT-A treatment for spasticity
January 21, 2019An international survey conducted by biopharmaceutical group Ipsen and social media platform Carenity found a significant hidden burden associated with spasticity and 94% satisfaction with .... -
People With Movement Disorders May Become Immune to Botox Therapy
December 29, 2018Some people who receive botulinum toxin injections for disorders that cause muscle tightness and contractions develop resistance to the treatment, researchers say.
Pharma Sources Insight January 2025
